Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Rubinstein, Mark
Item TypeName
Academic Article Antiviral CD4+ memory T cells are IL-15 dependent.
Academic Article The lymphopenic environment of CD132 (common gamma-chain)-deficient hosts elicits rapid homeostatic proliferation of naive T cells via IL-15.
Academic Article Soluble IL-15/IL-15Ra complexes in human serum.
Academic Article Efficacy and mechanism-of-action of a novel superagonist interleukin-15: interleukin-15 receptor aSu/Fc fusion complex in syngeneic murine models of multiple myeloma.
Academic Article Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}.
Academic Article An intense form of homeostatic proliferation of naive CD8+ cells driven by IL-2.
Academic Article Interleukin-15/interleukin-15R alpha complexes promote destruction of established tumors by reviving tumor-resident CD8+ T cells.
Academic Article IL-7 and IL-15 differentially regulate CD8+ T-cell subsets during contraction of the immune response.
Academic Article Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Ralpha complexes.
Concept Interleukin-15 Receptor alpha Subunit
Concept Interleukin-15
Concept Receptors, Interleukin-15
Academic Article IL-2Ra mediates temporal regulation of IL-2 signaling and enhances immunotherapy.
Academic Article Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7Ra Dependent.
Academic Article Molecular Programming of Tumor-Infiltrating CD8+ T Cells and IL15 Resistance.
Academic Article A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses.
Academic Article Murine Th17 cells utilize IL-2 receptor gamma chain cytokines but are resistant to cytokine withdrawal-induced apoptosis.
Academic Article ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial.
Academic Article Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8+ T Cells.
Academic Article Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Ra Complexes Enhances Tumor Control.
Academic Article Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy Volunteers.
Search Criteria
  • Interleukin 15